|
18 Jun 2019 |
Japan becomes the first country to approve Roche’s personalised medicine Rozlytrek
|
|
18 Jun 2019 |
Promedior Presents Positive Data from a Phase 2 Study of PRM-151 in Myelofibrosis Patients Failed/Ineligible for Ruxolitinib at the 24th European Hematology Association Annual Congress
|
|
18 Jun 2019 |
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH)
|
|
18 Jun 2019 |
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings
|
|
18 Jun 2019 |
RIBOMIC Announces Positive Top-Line Results from the Phase 1/2a Clinical Trial of RBM-007 (SUSHI Study) in Subjects with Wet Age-Related Macular Degeneration
|
|
18 Jun 2019 |
ArQule Announces Preliminary Results from Its Phase 1/2 Study of Miransertib (ARQ 092), in Patients with PIK3CA-related Overgrowth Spectrum (PROS) and Proteus syndrome (PS) in an Oral Presentation at the European Society of Human Genetics Conference
|
|
18 Jun 2019 |
Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis
|
|
18 Jun 2019 |
Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors
|
|
18 Jun 2019 |
Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer
|
|
18 Jun 2019 |
FDA approves Victoza® for the treatment of type 2 diabetes in children and adolescents aged 10-17 years
|
|
17 Jun 2019 |
VBI Vaccines Announces Positive Top-Line Results from PROTECT, a Pivotal Phase 3 Study of Sci-B-Vac
|
|
17 Jun 2019 |
BeiGene Regains Full Global Rights to Its Investigational Anti-PD-1 Antibody Tislelizumab
|
|
17 Jun 2019 |
Homology Medicines Presents Data Showing Single Dose HMI-102 Resulted in Long-Term Correction of PKU, Including Reduction of Phe and Increased Brain Neurotransmitters in Murine Model
|
|
17 Jun 2019 |
Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
|
|
17 Jun 2019 |
TG Therapeutics Presents Preclinical Data for TG-1801, a First-in-Class Anti-CD47/CD19 Bispecific Antibody, at the 24th European Hematology Association Annual Congress
|
|
17 Jun 2019 |
Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38
|
|
17 Jun 2019 |
Cellular Biomedicine Group Announces First Patient Dosing in Phase I Clinical Trial of Anti-CD20 CAR-T for Lymphoma in China
|
|
17 Jun 2019 |
Intralytix, the Eliava Foundation and Ferring Pharmaceuticals Sign Joint Collaboration Agreement for Reproductive Medicine and Women's Health Initiatives
|
|
17 Jun 2019 |
BioNTech and Genmab Initiate First-In-Human Phase I/IIa Trial of Bispecific Antibody DuoBody®-PD-L1x4-1BB in Solid Tumors
|
|
17 Jun 2019 |
Pfizer to Acquire Array BioPharma
|
